Ziwei Pan
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
TMC6 Is a Novel Therapeutic Target for Pathogenic Cardiac Hypertrophy.
Journal: Circulation research
Published: February 25, 2026
Decreased RYR2 Cluster Size and Abnormal SR Ca2+ Release Contribute to Arrhythmogenesis in TMEM43-Related ARVC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 30, 2025
Excessive autophagic degradation of MYLK3 causes sunitinib-induced cardiotoxicity.
Journal: Autophagy
Published: June 26, 2025
Heavy Metal Exposure and Cardiovascular Disease.
Journal: Circulation research
Published: April 25, 2024
Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy.
Journal: Handbook of experimental pharmacology
Published: July 08, 2023
Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation.
Journal: Clinical and translational medicine
Published: July 30, 2021
Characterization of the molecular mechanisms underlying azithromycin-induced cardiotoxicity using human-induced pluripotent stem cell-derived cardiomyocytes.
Journal: Clinical and translational medicine
Published: June 22, 2021
Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
Journal: Pflugers Archiv : European journal of physiology
Published: August 21, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026